Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia

Experimental and Molecular Pathology

Volumn 88, Issue 2, 2010, Pages 293-298

  Kuninaka, Nobuo ^a,b   Kurata, Morito ^a   Yamamoto, Kouhei ^a   Suzuki, Shiho ^a   Umeda, Shigeaki ^a   Kirimura, Susumu ^a   Arai, Ayako ^a   Nakagawa, Yasunori ^c   Suzuki, Kenshi ^c   Kitagawa, Masanobu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b National Center Hospital of Neurology and Psychiatry   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Bone marrow; Myelodysplastic syndromes; Overt leukemia; Toll like receptor; Transformation

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MALE; MALIGNANT TRANSFORMATION; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANEMIA, REFRACTORY; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77950629227     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.01.009     Document Type: Article

References (36)

1. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Aliprantis A.O., et al. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 2000, 19:3325-3236.
4. Andreakos E., et al. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?. Immunol. Rev. 2004, 202:250-265.
5. Benesch M., et al. Expression of FLIP (Long) and FLIP (Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis. Leukemia 2003, 17:2460-2466.
6. Bennett J.M. A comparative review of classification systems in myelodysplastic syndromes (MDS). Semin. Oncol. 2005, 32:S3-S10.
7. Beutler B.A. TLRs and innate immunity. Blood 2009, 113:1399-1407.
8. Campioni D., et al. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am. J. Pathol. 2005, 166:557-563.
9. Claessens Y.E., et al. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood 2002, 99:1594-1601.
10. Ehlers M., Ravetch J.V. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol. 2007, 28:74-79.
11. Fan W., et al. Overexpression of TLR2 and TLR4 susceptibility to serum deprivation-induced apoptosis in CHO cells. Biochem. Biophys. Res. Commun. 2005, 337:840-848.
12. Gupta P., et al. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Leukemia 1999, 13:44-53.
13. Haase R., et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J. Immunol. 2003, 171:4294-4303.
14. Han S.B., et al. Toll-like receptormediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanaxsenticosus. Int. Immunopharmacol. 2003, 3:1301-1312.
15. Harris N.L., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J. Clin. Oncol. 1999, 17:3835-3849.
16. Ishii M., et al. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur. J. Immunol. 2008, 38:2290-2302.
17. Jiang D., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
18. Katsoulidis E., et al. Role of the p38 mitogen-activated protein kinase pathway in cytokine mediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res. 2005, 65:9029-9037.
19. Kawai T., et al. Lipopolysaccharide stimulates theMyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
20. Kitagawa M., et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997, 11:2049-2054.
21. Kitagawa M., et al. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia 1998, 12:486-492.
22. Lamb R.J., et al. Identification and characterization of novel bone marrow myeloid DEC205+Gr-1+ cell subsets that differentially express chemokine and TLRs. J. Immunol. 2007, 178:7833-7839.
23. Lim E.J., et al. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling. FEBS Lett. 2006, 580:4533-4538.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
25. Maratheftis C.I., et al. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin. Cancer Res. 2007, 15:1154-1160.
26. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
27. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol 2001, 1:135-145.
28. Rakoff-Nahoum S., Medzhitov R. Toll-like receptors and cancer. Nat. Rev. Cancer 2009, 9:57-63.
29. Raza A., et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995, 86:268-276.
30. Sawanobori M., et al. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leukemia Res. 2003, 27:583-591.
31. Schmitt A., et al. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Transfusion 2008, 48:861-870.
32. Takeda K., et al. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-276.
33. Tsan M.F. Toll-like receptors, inflammation and cancer. Semin. Cancer Biol. 2006, 16:32-37.
34. Yamamoto K., et al. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leukemia Res. 2004, 28:1203-1211.
35. Zamai L., et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 2000, 95:3716-3724.
36. Zang D.Y., et al. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 2001, 98:3058-3065.